Cardinal Health (CAH) FY2019 results: revenue $145.5 billion, up 6.4% on the year
Cardinal Health Inc. (CAH) reported revenue of $145.5 billion for fiscal 2019, the year ended 30 June 2019, up 6.4% on the year before. Net income was $1.4 billion, up 432.4%, and diluted earnings per share $4.53. The figures are the company's own, from the 10-K it filed with the SEC on 20 August 2019.
Revenue
$145.5 billion
+6.4% on the year
FY2012FY2019
Operating margin
1.4%
0.1% a year earlier
FY2012FY2019
Net income
$1.4 billion
+432.4% on the year
FY2012FY2019
Diluted EPS
$4.53
+459.3% on the year
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
145,534
136,809
129,976
+6.4%
Cost of revenue
138,700
129,628
123,432
+7.0%
Gross profit
6,834
7,181
6,544
-4.8%
Gross margin
4.7%
5.2%
5.0%
Selling, general and administrative
4,480
4,596
3,775
-2.5%
Operating income
2,060
126
2,120
+1,534.9%
Operating margin
1.4%
0.1%
1.6%
Interest expense
294
329
201
-10.6%
Pre-tax income
1,751
-228
1,924
Income tax
386
-487
630
Effective tax rate
22.0%
n/a
32.7%
Net income
1,363
256
1,288
+432.4%
Net margin
0.9%
0.2%
1.0%
Diluted EPS
$4.53
$0.81
$4.03
+459.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
2,722
2,768
1,184
-1.7%
Capital expenditure
328
384
387
-14.6%
Free cash flow
2,394
2,384
797
+0.4%
Free cash flow margin
1.6%
1.7%
0.6%
Cash from investing
338
-5,608
-405
Cash from financing
-2,293
-2,276
3,746
Depreciation and amortisation
1,000
1,032
717
-3.1%
Share-based compensation
82.0
85.0
96.0
-3.5%
Buybacks
600
550
600
+9.1%
Dividends paid
577
581
577
-0.7%
Dividend per share
$1.91
$1.85
$1.80
+3.2%
Diluted shares, weighted
301m
315m
320m
-4.4%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
6,328
6,059
6,808
+4.4%
Non-controlling interest
2.0
0.0
20.0
Redeemable equity
0.0
12.0
118
Debt
8,031
9,013
10,395
-10.9%
Other liabilities
26,602
24,867
22,771
+7.0%
Total liabilities and equity
40,963
39,951
40,112
+2.5%
Fixed assets
2,356
2,487
1,879
-5.3%
Goodwill
8,378
8,316
7,221
+0.7%
Intangible assets
3,430
3,913
1,986
-12.3%
Investments
n/a
n/a
65.0
Cash and equivalents
2,531
1,763
6,879
+43.6%
Receivables
8,448
7,800
8,048
+8.3%
Inventory
12,822
12,308
11,301
+4.2%
Other assets
2,998
3,364
2,733
-10.9%
Total assets
40,963
39,951
40,112
+2.5%
10-K for the year ended 30 June 2019, filed 20 August 2019: the filing.